(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FONZOR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

FONZOR

ST13

US500000097387130

Class

5

Filing

97387130

Registration

6913180

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

12/21/2024

Trademark type

Word

Nice classes

5

Filing date

04/28/2022

Registration date

11/29/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/29/2022

Last transaction

12/21/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

Leverkusen, DE

Examiner

IN, SUNG HYUN

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

B. A. (pessoa física)

Representatives

Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of chronic cough diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of overactive bladder diseases and disorders; pharmaceutical preparations for the treatment of hormonal diseases and disorders; pharmaceutical preparations for the treatment of endometriosis diseases and disorders; pharmaceutical preparations for the treatment of cystic diseases and disorders; pharmaceutical preparations for the treatment of pain diseases and disorders; pharmaceutical preparations for the treatment of neurologic diseases and disorders; pharmaceutical preparations for the treatment of neuropathic pain diseases and disorders; pharmaceutical preparations for the treatment of sensory diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders

Publications

History of USPTO decisions and trademark events.

17 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/17/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/17/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/17/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/29/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/29/2022

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/26/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/26/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

10/05/2022

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

10/05/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/27/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/02/2022

PUBO

PUBLISHED FOR OPPOSITION

08/02/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/13/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/27/2022

DOCK

ASSIGNED TO EXAMINER

06/25/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/03/2022

NWAP

NEW APPLICATION ENTERED

05/02/2022

Continuous trademark protection

Get notified about every new filing that threatens FONZOR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.